Form 4: Rocket Pharmaceuticals Director Reports Stock Transaction
Insider Transaction (Form 4)
David P Southwell, a Director of Rocket Pharmaceuticals, Inc., reported a transaction in 150,000 shares of common stock on August 3, 2026.
Summary
- Other acquisition/disposition: acquired 150,000 Common Stock on August 3, 2026; holds 204,522 after (Direct).
Sentiment
Score: 5
Explanation: StockSavvy.ai views this as routine: the reported changes are grants, option exercises, tax withholding or similar administrative transactions, which carry limited directional signal.
Insider Transactions
David P Southwell — Director
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-08-03 | Other acquisition/disposition | Common Stock | 150,000 | — | — | 204,522 |
Key Dates
| Date | Description |
|---|---|
| 2026-08-03 | Other acquisition/disposition (150,000 shares) |
Keywords
insider transaction, Form 4, RCKT, ROCKET PHARMACEUTICALS, INC., neutral, David P Southwell
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.